Navigation Links
Cancer Drug Reduced Relapses in MS Patients: Studies
Date:11/1/2012

THURSDAY, Nov. 1 (HealthDay News) -- The cancer drug alemtuzumab (Campath) reduces the risk of disease relapse in people with multiple sclerosis, two new trials show.

About 85 percent of multiple sclerosis patients start with a form of the disease called relapsing-remitting MS, where symptoms appear sporadically (a relapse) and then either partially or completely fade away. There is no cure for MS, and existing drugs only aim to reduce the symptoms of the disease.

MS occurs when the body's immune system starts to attack the coating of nerve fibers. Alemtuzumab, which is used to treat leukemia and other cancers of the immune system, works by altering the number, proportions and functions of certain types of lymphocytes, which are white blood cells that play a major role in the functioning of the immune system.

In these two clinical trials, British researchers led by Alastair Compston of the University of Cambridge compared alemtuzumab with interferon beta 1a, the most common drug used to treat MS.

The first trial included patients who had never received drug treatment for MS. The relapse rates after two years were 22 percent for those who were given alemtuzumab and 40 percent for those who were given interferon beta 1a.

The second trial included patients who had already been treated with either interferon beta 1a or another MS drug called glatiramer, but had suffered at least one relapse since their initial treatment. The relapse rates were 35 percent for patients who were given alemtuzumab and 51 percent for those who received interferon beta 1a, the investigators found.

The researchers also found that alemtuzumab appeared to reduce the risk of MS-related disability such as the loss of coordination or the ability to walk. Disability rates were 13 percent among those in the alemtuzumab group and 20 percent of those in the interferon beta 1a group. The first trial found no significant difference in disa
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. New Stool Test Might Aid in Early Detection of Colon Cancer
3. Study reveals how cancer drug causes diabetic-like state
4. How a cancer drug leads to diabetes
5. You Survived Cancer: Now Pay Attention to Your Overall Health
6. New drug prevents spread of human prostate cancer cells
7. Eliminating the good cholesterol receptor may fight breast cancer
8. Taller, Heavier Women May Face Higher Ovarian Cancer Risk
9. Experimental Chemo Combo for Colon Cancer Disappoints
10. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
11. Targeted therapeutics for colon cancer to be presented at AACR meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug Reduced Relapses in MS Patients: Studies
(Date:7/13/2014)... New York, New York (PRWEB) July 13, 2014 ... mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against ... the litigation’s second bellwether trial, which is expected to ... Control Order issued in the U.S. District Court, Southern ... Pretrial Conference will be held on August 7, 2014 ...
(Date:7/13/2014)... Rico (PRWEB) July 13, 2014 ... of Famer, Chris Mullin, will be the featured guest ... July 26th in Puerto Rico. Attendees will learn ... will participate in two exhibition basketball games and perform ... ultimate supplier of health- and energy-boosting supplements , ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Fadhits.com is ... sexy prom dresses are extremely beautiful. Recently, the company ... dresses for 2014. What’s more, all these outfits ... percent off). , Additionally, the supplier is now ... with elegant Quinceanera dresses, it has many other designs ...
(Date:7/13/2014)... noninvasive optical imaging device developed at Cedars-Sinai can ... in the brain and are a classic sign ... investigators conducting a clinical trial in Australia. , ... in an oral presentation at the Alzheimer,s Association ... were invited by conference organizers to participate in ...
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently ... on what to do to eliminate the root cause ... its review that readers can easily learn what foods to ... health. Vkool also informs in its Kidney Disease Solution review ... functions naturally. The book consists of a collection of natural ...
Breaking Medicine News(10 mins):Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 2Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 3Health News:Max International Announces NBA Dream Team Member Chris Mullin as Featured Guest of Charity Event 4Health News:Fadhits.com Announces a Special Offer on Elegant Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3
... Pinnacle health systems already achieving positive results following ... April 3 CentraState and Pinnacle health ... information technology to improve nursing practice as part ... www.siemens.com/healthcare ) experience at ...
... and Distribution Workflow Solution Provides Final Reports in ... UltraRAD Corp. and StructuRad LLC announce that ... now in production at Valor Network, Inc. The ... image management and reporting based on StructuRad,s StudyManager ...
... Foods to Donate $250,000 - 1.75 million meals ... Relief OrganizationOMAHA, Neb., April 3 Healthy Choice, ... completely reinvented - focusing on what people want ... for the frozen entree category. After 20 years ...
... Calif., April 3 IDM Pharma, Inc. (Nasdaq: ... of innovative cancer products, including MEPACT(R) (known as mifamurtide ... Europe for the treatment of osteosarcoma, today announced that ... 31, 2008, included in the Annual Report on Form ...
... Betsy Vasquez, MD announced today the opening of AVIE!, their new medical ... Plaza II. , ... Leesburg, VA (PRWEB) April 3, 2009-- Kim ... and Laser Center is officially open for business at their Fort Evans ...
... 2 As news emerged that Gov. Kathleen ... has been postponed until the end of April, ... Brownback and Pat Roberts to reject the nomination.(Logo: ... on "Senatorial Courtesy" -- the longstanding Senate tradition ...
Cached Medicine News:Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 2Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 3Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 4Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 2Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 2Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 4Health News:IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 3Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2
(Date:7/11/2014)... 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a ... use in portable vaporizers, which contains CBD, or ... cannabis, cannabidiol offers consumers a THC-free product made ... vaporizer technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... different compounds which are currently known, two of ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the "Global and Chinese Medical X-ray Film Industry ... http://photos.prnewswire.com/prnh/20130307/600769 Global And ... professional and in-depth study on the current state of ... on the Chinese situation. The report provides a ...
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery ... that it has raised A$19.3 million via a placement ... Europe , the U.S., Asia ... million from a share purchase plan (SPP) to be ... will be made in two tranches. "This ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2Global and Chinese Medical X-ray Film Industry Report 2014 2Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3
... NANJING , China , April 21 ... SCR ), a leading pharmaceutical company,specializing in ... pharmaceuticals in China , today announced that its,diosmectite, ... Biqi, has passed EU-GMP inspection. This enables Simcere to,market ...
... , April 21 PharmaMar, a biopharmaceutical company ... drugs Yondelis(R), Zalypsis(R) and Irvalec(R) at the American Association for Cancer Research,s ... April 17-21 . , , ... AACR meeting is the leading convention on cancer research, bringing together more ...
Cached Medicine Technology:Simcere's Diosmectite API Passes EU-GMP Inspection 2PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 2PharmaMar Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 3
... dermal matrix derived from donated human skin ... utilizing the standards of the American Association ... Drug Administration's (FDA) guidelines. Since AlloDerm is ... changed in structure from the natural material, ...
... a sterile off white, moist, tough but ... and its constituent elastin fibres presented moist ... ready to use in double vacuum packed ... oxygen, and is sterilised by gamma irradiation. ...
... TONO-PEN AVIA tonometer is an easy-to-use, ... that correlate strongly with Goldmann tonometry. ... design and advanced electronic measurement technology ... and accurate IOP measurements with minimal ...
... The Invisio Digital Flexible Ureteroscope ... features from the proven durable, market ... is also the first device utilizing ... 1 mm Complementary Metal Oxide Semi-Conductor ...
Medicine Products: